Xiaoying J. Ying - Publications

Peptide-functionalized gold nanoparticles for boron neutron capture therapy with the potential to use in Glioblastoma treatment.

Journal: Pharmaceutical development and technology

Published: September 17, 2024

Establishing a Device for Sleep Deprivation in Mice.

Journal: Journal of visualized experiments : JoVE

Published: October 09, 2023

Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.

Journal: Cellular signalling

Published: January 16, 2023

Biochemical and biophysical properties of an unreported T96R mutation causing transthyretin cardiac amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: November 09, 2022

Microwave hyperthermia-responsible flexible liposomal gel as a novel transdermal delivery of methotrexate for enhanced rheumatoid arthritis therapy.

Journal: Biomaterials science

Published: November 17, 2021

ICAM-1 targeted thermal-sensitive micelles loaded with tofacitinib for enhanced treatment of rheumatoid arthritis via microwave assistance.

Journal: Biomaterials advances

Published: October 26, 2021

Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 26, 2021

Topical application of HA-g-TEMPO accelerates the acute wound healing via reducing reactive oxygen species (ROS) and promoting angiogenesis.

Journal: International journal of pharmaceutics

Published: September 01, 2020

Tofacitinib citrate-based liposomes for effective treatment of rheumatoid arthritis.

Journal: Die Pharmazie

Published: April 17, 2020

Cyto-friendly polymerization at cell surfaces modulates cell fate by clustering cell-surface receptors.

Journal: Chemical science

Published: March 25, 2020

ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule.

Journal: Science advances

Published: March 15, 2020

Sialic acid-modified chitosan oligosaccharide-based biphasic calcium phosphate promote synergetic bone formation in rheumatoid arthritis therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 16, 2020